Management of autoimmune bullous diseases: Pharmacology and therapeutics

Mutasim, Diya F.

doi:10.1016/j.jaad.2004.02.013

Cited by 63 publications

(56 citation statements)

References 165 publications

(164 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…An adjuvant drug is prescribed for most patients with severe PV, with the objectives of reducing the cortisone dose and ensuring stable remission. However, the use of adjuvant therapy remains controversial (Mutasim 2004). …”

Section: Intralesional Corticosteroid Therapymentioning

confidence: 99%

See 1 more Smart Citation

Role of Corticosteroids in Oral Lesions

Mehdipour¹,

Zenouz²

2012

State of the Art of Therapeutic Endocrinology

View full text Add to dashboard Cite

Section: Intralesional Corticosteroid Therapymentioning

confidence: 99%

“…Potent topical corticosteroids should be considered in patients with limited or moderate disease (Mutasim 2004). …”

Section: Topical Steroid Therapymentioning

confidence: 99%

Role of Corticosteroids in Oral Lesions

Mehdipour¹,

Zenouz²

2012

State of the Art of Therapeutic Endocrinology

View full text Add to dashboard Cite

“…Мильтон, 1872), затем пруриго бере-менных Бенье (Е. Бенье, 1904), который в течение многих лет выполнял роль «спасательного круга»: любое кожное заболевание, кроме ГБ, диагностиро-валось как пруриго беременных Бенье [13][14][15][16][17][18].…”

Section: исторический обзорunclassified

A view of the problem of pregnancy-specific skin dermatoses. Part I

Khachikian¹,

Karapetian²

2014

Klin. dermatol. venerol.

View full text Add to dashboard Cite

“…Kan kortizolu 10 μg/ dl'nin üzerindeyse bazal adrenal kortizol sekresyonu yeterlidir ve kortikosteroid kesilebilir. 24 Pemfigustaki standart tedavi şeması; 'Viyana ekolü' şemasıdır. Bu şema KS ve azatiopurin kombine tedavisine dayanmaktadır.…”

Section: Sürdürme (Idame) Fazıunclassified

Pemphigus

Uçmak

2011

J Clin Exp Invest

View full text Add to dashboard Cite

ÖZETPemfigus deri ve mükoz membranların büllöz, sık gö-rülmeyen otoimmün kökenli bir hastalığıdır. Hastalığın patogenezinde keratinosit yüzeyindeki proteinlere karşı gelişen otoantikorların önemli rolü mevcuttur. Pemfigusun insidansı hastalığın tipine göre ülkeden ülkeye değişiklik gösterir. Pemfigus vulgaris tüm pemfigusluların yaklaşık %80'nini oluşturmaktadır ve pemfigus foliaseustan 10 kat daha fazla gözlenmektedir. Tedavide başta sistemik glukokortikoidler olmak üzere çeşitli immünsupresifler kullanılmaktadır ve son yıllarda yeni tedavi ajanları geliştirilmiştir. Bu derlemede pemfigus epidemiyolojisi, patogenezi, kliniği ve tedavisi güncel bilgiler ışığında gözden geçirilmiştir. Anahtar kelimeler: Büllöz hastalıklar, pemfigus, kortikosteroidler, tedavi ABSTRACTPemphigus is an uncommon autoimmune mucocutaneous blistering disease, mediated by antibodies directed against proteins present on the surface of keratinocytes that provide mechanical structure to the epidermis. Incidences of the various forms of pemphigus vary from country to country. Pemphigus vulgaris consists of the 80% of pemphigus cases and it occurs 10 times more than pemphigus foliaceus. There have been several recent advances in the management of pemphigus. Treatment of with systemic steroids and cytotoxic immunosuppressants can be highly effective. This article will discuss its epidemiology, pathogenesis, clinical variants and approaches to treatment. J Clin Exp Invest 2011; 2 (4): 468-473

show abstract

Management of autoimmune bullous diseases: Pharmacology and therapeutics

Cited by 63 publications

References 165 publications

Role of Corticosteroids in Oral Lesions

Role of Corticosteroids in Oral Lesions

A view of the problem of pregnancy-specific skin dermatoses. Part I

Pemphigus

Contact Info

Product

Resources

About